Effects of multimorbidity coexistence on the risk of mortality in the older adult population in China
Bibliographic Data
| ID | 22072113 |
|---|---|
| Authors | Zhili Su (0000-0001-9110-0573, Wenzhou Medical University), Li Huang (0000-0001-5365-7899), Huang Li (0000-0002-8117-7793, Wenzhou Medical University), Jinghui Zhu (0000-0002-0007-6916, Wenzhou Medical University, corresponding author), Shichen Cui (Wenzhou Medical University, corresponding author) |
| Year | 2023 |
| Volume | 11 |
| Pages | 1110876-1110876 |
| Publication date | 2023-04-05 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2023.1110876 |
| PMID | 37089511 |
| OpenAlex | W4362623059 |
| Language | EN |
| Citations received | 6 |
| References cited | 24 |
Background: Multimorbidity coexistence is a serious public health issue affecting a significant number of older adults worldwide. However, associations between multimorbidity and mortality are rarely studied in China. We assessed the effects of multimorbidity coexistence on mortality among a nationwide sample of older adults from China. Objective: We analyzed 10-year (2008-2018) longitudinal data of 12,337 individuals who took part in China, a nationwide survey of people aged 65 years and above. We used the Cox proportional hazard model to determine the effects of multimorbidity on the all-cause mortality risk. We also examined mortality risk between sex and age obtained through differential analysis. Results: At baseline, 30.2, 29.9, and 39.9% of participants had 0, 1, and 2 or more diseases, respectively. The cumulative follow-up of this study was 27,428 person-years (median follow-up = 2.7 years; range, 0.01-11.3 years), with 8297 deaths. The HRs (95% CIs) for all-cause mortality in participants with 1, and 2 or more conditions compared with those with none were 1.04 (0.98, 1.10) and 1.12 (1.06, 1.18), respectively. The heterogeneity analysis indicated that, the mortality risk for 80-94 years and 95-104 years group with multimorbidity coexistence is 1.12 (1.05-1.21) and 1.11 (1.01-1.23), respectively, but the mortality risk for 65-79 years group with multimorbidity coexistence was not statistically significant. The heterogeneity analysis indicated that, the mortality risk for men and women in older adults with multimorbidity coexistence is 1.15 (1.06, 1.25) and 1.08 (1.01, 1.17), respectively. Conclusion: Multimorbidity coexistence is associated with an increase in an increased risk of death in older individuals, with the effect being relatively significant in those aged 80-94 years
China · Confidence interval · Environmental health · Geography · Hazard ratio · Multimorbidity · Population · Proportional hazards model · Chronic Disease Management Strategies · Demography · Healthcare Systems and Reforms · Medicine · Primary Care and Health Outcomes · Epidemiology · Gerontology · Internal Medicine
Prevalence of multimorbidity among urban–rural older adults in Mongolia
Trajectories network analysis of chronic diseases among middle-aged and older adults
Association between physical multimorbidity in middle adulthood and mortality
Network analysis of chronic disease among middle-aged and older adults in China
Risk prediction models for mortality in patients with multimorbidity
Intersectional analysis of social determinants of health and their association with mortality in patients with multimorbidity
Multimorbidity and mortality in older adults
Multimorbidity
Associations between Multimorbidity and Physical Performance in Older Chinese Adults
Relationship of Multimorbidity, Obesity Status, and Grip Strength among Older Adults in Taiwan
Relationship between multimorbidity, disease cluster and all-cause mortality among older adults
Toward deeper research and better policy for healthy aging – using the unique data of Chinese longitudinal healthy longevity survey
| Unique citing works | 6 |
|---|---|
| Citations per year | 3 |
| Citation span | 2024 - 2025 (2) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 6 |